Similarly, western blot analyses of lysates of CRC and BC cells revealed that VEGF-A protein was significantly decreased in cells treated with Nef-M1 peptide compared to cells treated with sNef-M1 peptide control samples (Figure 3E & 4E). This evidence concerns the gene S100B and breast cancer.